Neurocosmetic:XOMD skin have arrived on EU market
- Editor

- Mar 14
- 2 min read
Updated: Mar 15

XOMD Skincare, the first clinically proven "Moodceutical", designed to elevate both skin quality and emotional well-being, is officially expanding into Europe.
Coined for its ability to improve the appearance of skin through ameliorating the user's mood, XOMD Skincare is inspired by oxytocin, "the love hormone", for that fresh-faced glow worn by lovers.
Co-created by world-renowned aesthetic physicians Dr. Sabrina Fabi and Dr. Steven Dayan, XOMD explores the intersection of dermatology, neuroscience and their effects on emotional well-being.
Although XOMD does not include oxytocin, its formulas are crafted to replicate the pathways linked with oxytocin, which are associated with bonding, confidence, calmness, and connection.
In a thorough, randomized, double-blind, placebo-controlled clinical trial, XOMD showed enhancements not only in skin brightness, smoothness, and tone, but also in self-esteem, perception of attractiveness, social confidence, and intimacy metrics—marking a completely new category in aesthetics.
The emerging category of neurocosmetics acknowledges the skin’s relationship to the nervous and endocrine systems, and recognizes that how we feel emotionally can influence how we look physically. This is not a marketing trend, but a scientific reality.
By supporting the oxytocin signaling system in the skin, we observe a novel approach to longevity—one that aligns with how the body actually functions under conditions of safety, care and connection. It's not about fighting the skin into
submission. It's about helping it to work better, naturally.
With advances in neurobiology and dermatological research, skin care is finally starting to reflect that idea. We are entering an era where longevity isn't just about reversing damage or masking imperfections. It's about supporting the skin’s own intelligence and acknowledging the role that hormones, emotions and connection play in how we age.




Comments